Studies support dexmedetomidine for ICU ventilation patients

03/22/2012 | MedPage Today (free registration)

Dexmedetomidine, a lighter sedative that does not have respiratory depressive effects, was as effective as midazolam or propofol for long-term sedation in ventilated ICU patients, Bern University researchers reported in two studies in the Journal of the American Medical Association. Data also showed dexmedetomidine may reduce the duration of ventilation and that patients were more easily aroused and better able to communicate with staff compared with those on midazolam.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC